Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ''Healthy China''

Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ”Healthy China”

SHANGHAI, Nov. 8, 2024 /PRNewswire/ — Illumina Hong Kong LIMITED (Illumina), a global leader in DNA sequencing and array-based technologies, and PHASE Scientific International Limited (PHASE), a Hong Kong-based biotech company with operations in the U.S. and the Greater Bay Area (GBA), signed a three-year Memorandum of Understanding (MoU) on 7 November at the 7th…

Read More